| Line Item | 2022-11-30 | Y/Y |
|---|---|---|
| Revenue | $9K | — |
| Cost of Revenue | $733 | — |
| Gross Profit | -$6K | — |
| R&D Expense | $0 | — |
| SG&A Expense | $852K | — |
| Operating Income | -$2.3M | — |
| Net Income | -$2.4M | — |
| EPS (Basic) | -$0.01 | — |
| EPS (Diluted) | -$0.01 | — |
| Line Item | 2022-11-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3K | — |
| Accounts Receivable | $1K | — |
| Inventory | $2K | — |
| Current Assets | $138K | — |
| Total Assets | $723K | — |
| Current Liabilities | $799K | +192.0% |
| Total Liabilities | $1.4M | +411.7% |
| Stockholders' Equity |
| Line Item | 2022-11-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$755K | — |
| Investing Cash Flow | -$8K | — |
| Financing Cash Flow | $757K | — |
| -$678K |
| -147.5% |